TICKERNOMICS Sign up
Last Update: 2023-12-23 06:01:44
908 Devices Inc. ( MASS ) https://www.908devices.com
9.12USD
Sector:
Healthcare
Industry:
Medical Devices
Country:
United States
1y
3y
5y
10y
Historical Returns*:
SPY
23.45%
MASS
24.76%
SPY
30.72%
-85.24%
MASS
SPY
112.82%
MASS
0.00%
SPY
201.04%
MASS
0.00%
*Assumes dividends reinvested
Market Stats:
Market Capitalization($MM)
Enterprise Value($MM)
Daily Volume(MM)
247.45
224.16
0.18
Valuation Metrics:
Price/Earnings Ratio
Price/Sales Ratio
Price/Book Value
FCF Yield(%)
Dividend Yield(%)
EV/EBITDA
-6.77
5.21
1.46
-9.51
0.00
-5.49
Profitability Stats:
Operating Margin %(ttm)
Gross Profit %(ttm)
EBITDA Margin %(ttm)
-63.57
55.04
-85.91
Shareholder Value Creation:
Cost of Capital %(est)
ROIC %(ttm)
ROCE %(ttm)
Beta
3.86
-17.00
-17.95
0.00
Other Earnings and Cash Flow Stats:
908 Devices Inc. ( MASS ) Net Income TTM ($MM) is -32.56
908 Devices Inc. ( MASS ) Operating Income TTM ($MM) is -39.60
908 Devices Inc. ( MASS ) Owners' Earnings Annual ($MM) is 0.00
908 Devices Inc. ( MASS ) Current Price to Owners' Earnings ratio is 0.00
908 Devices Inc. ( MASS ) EBITDA TTM ($MM) is -36.26
908 Devices Inc. ( MASS ) EBITDA Margin is -85.91%
Capital Allocation:
908 Devices Inc. ( MASS ) has paid 0.00 dividends per share and bought back -0.739441 million shares in the past 12 months
908 Devices Inc. ( MASS ) has reduced its debt by 14.893 million USD in the last 12 months
Capital Structure:
908 Devices Inc. ( MASS ) Interest-bearing Debt ($MM) as of last quarter is 6
908 Devices Inc. ( MASS ) Annual Working Capital Investments ($MM) are -164
908 Devices Inc. ( MASS ) Book Value ($MM) as of last quarter is 169
908 Devices Inc. ( MASS ) Debt/Capital as of last quarter is 3%
Other Balance Sheet Stats:
908 Devices Inc. ( MASS ) has 118 million in cash on hand as of last quarter
908 Devices Inc. ( MASS ) has 22 million of liabilities due within 12 months, and long term debt 15 as of last quarter
908 Devices Inc. ( MASS ) has 32 common shares outstanding as of last quarter
908 Devices Inc. ( MASS ) has 0 million USD of preferred stock value
Academic Scores:
908 Devices Inc. ( MASS ) Altman Z-Score is 3.20 as of last quarter
908 Devices Inc. ( MASS ) Piotroski Score is 3.00 as of last quarter
Corporate Governance:
908 Devices Inc. ( MASS ) largest shareholder is Nikko Asset Management Americas Inc owning 629994 shares at 5.75 ($MM) value
Kevin J Knopp(an insider) Sold 15158 shares of 908 Devices Inc. ( MASS ) for the amount of $155975.82 on 2023-02-15
8.00% of 908 Devices Inc. ( MASS ) is held by insiders, and 86.53% is held by institutions
908 Devices Inc. ( MASS ) went public on 2020-12-18
Other 908 Devices Inc. ( MASS ) financial metrics:
FCF:-28.05
Unlevered Free Cash Flow:0.00
EPS:-0.88
Operating Margin:-63.57
Gross Profit Margin:55.04
Div. Payout Ratio%:0.00
Div. Growth YoY%:0.00
Equity Return%:-16.70
Beta:0.00
Buffet's Owners Earnings:0.00
Price to Owner's Earnings:0.00
About 908 Devices Inc. ( MASS ) :
908 Devices Inc., a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry (Mass Spec) devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, industrial biotech, forensics, and adjacent markets. The company's products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of gas, liquid, and solid materials of unknown identity; Rebel, a small desktop analyzer that provides real-time information on the extracellular environment in bioprocesses; Maven and Trace C2, an online device for bioprocess monitoring and control; and ZipChip solution, a plug-and-play, high-resolution separation platform that optimizes Mass Spec sample analysis. It operates in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. 908 Devices Inc. was incorporated in 2012 and is headquartered in Boston, Massachusetts.
User Content from Tickernomics. Created by Luminus.
DISCLAIMER

This web site and its creators are not certified financial advisors. All opinions/suggestions expressed on this website should not be treated as specific inducement to make a particular investment or follow a particular strategy, but only as an expression of an opinion.The Company doesn't warrant the information provided on the website for its completeness or accuracy, and it should not be relied upon as such. The Company is not under any obligation to update or correct any information provided on this website.The content of this website is published in the United States of America and persons who access it agree to do so in accordance with applicable U.S. law.Past performance is not indicative of future results. The Company doesn't guarantee any specific outcome or profit. You should be aware of the real risk of loss in following any strategy or investment discussed on this website.Strategies or investments discussed may fluctuate in price or value. Investors may get back less than invested. Investments or strategies mentioned on this website may not be suitable for you. This material does not take into account your particular investment objectives,financial situation or needs and is not intended as recommendations appropriate for you. You must make an independent decision regarding investments or strategies mentioned on this website. Before acting on information on this website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser.